Our goal is that we will be able to have public disclosure of all the data and ultimately, we hope to be able to bring it back to patients in need. |
We launched an extensive safety evaluation in collaboration with leading experts in PML and MS. We set up an independent adjudication committee to review any and all cases of PML. |
We're going back to patients who were in our earlier trials. There were about 2,000 who participated and we're encouraged that a high percentage of patients have expressed a desire to enroll in this study. |